DK1707198T3 - Middel til forebyggelse eller lindring af leversygdom forbundet med hepatopati - Google Patents
Middel til forebyggelse eller lindring af leversygdom forbundet med hepatopatiInfo
- Publication number
- DK1707198T3 DK1707198T3 DK05704085.9T DK05704085T DK1707198T3 DK 1707198 T3 DK1707198 T3 DK 1707198T3 DK 05704085 T DK05704085 T DK 05704085T DK 1707198 T3 DK1707198 T3 DK 1707198T3
- Authority
- DK
- Denmark
- Prior art keywords
- hepatopathy
- relief
- medicine
- prevention
- health disease
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000019423 liver disease Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004012207A JP4721642B2 (ja) | 2004-01-20 | 2004-01-20 | 肝障害を伴う肝臓疾患の予防又は改善剤 |
| PCT/JP2005/000941 WO2005067914A1 (ja) | 2004-01-20 | 2005-01-19 | 肝障害を伴う肝臓疾患の予防又は改善剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1707198T3 true DK1707198T3 (da) | 2013-01-28 |
Family
ID=34792369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05704085.9T DK1707198T3 (da) | 2004-01-20 | 2005-01-19 | Middel til forebyggelse eller lindring af leversygdom forbundet med hepatopati |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8436047B2 (da) |
| EP (1) | EP1707198B1 (da) |
| JP (1) | JP4721642B2 (da) |
| CN (1) | CN1842329B (da) |
| AU (1) | AU2005205662B2 (da) |
| CA (1) | CA2540272C (da) |
| DK (1) | DK1707198T3 (da) |
| WO (1) | WO2005067914A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
| JP2012041283A (ja) * | 2010-08-17 | 2012-03-01 | Porien Project Kk | 血管新生抑制剤 |
| CN105181832A (zh) * | 2015-08-31 | 2015-12-23 | 广州金域医学检验中心有限公司 | 一种快速检测全血红细胞二十烷二烯酸的方法 |
| CN105241969B (zh) * | 2015-08-31 | 2018-03-02 | 西安金域医学检验所有限公司 | 一种快速检测全血红细胞二十二烷四烯酸的方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4432906A (en) * | 1981-09-14 | 1984-02-21 | Hoffmann-La Roche Inc. | Inhibitors of SRS-synthesis |
| US4434101A (en) * | 1981-09-14 | 1984-02-28 | Hoffmann-La Roche Inc. | Inhibitors of SRS-synthesis |
| GB8302708D0 (en) * | 1983-02-01 | 1983-03-02 | Efamol Ltd | Pharmaceutical and dietary composition |
| JPS62195346A (ja) | 1984-11-19 | 1987-08-28 | Sumitomo Pharmaceut Co Ltd | 新規不飽和脂肪酸誘導体 |
| JPS6372648A (ja) | 1986-09-16 | 1988-04-02 | Sumitomo Pharmaceut Co Ltd | 新規不飽和脂肪酸誘導体 |
| JPH066211Y2 (ja) | 1987-02-24 | 1994-02-16 | トヨタ自動車株式会社 | エンジンの吸気制御装置 |
| JPS6426532U (da) | 1987-08-10 | 1989-02-15 | ||
| US5320846A (en) * | 1991-04-17 | 1994-06-14 | New England Deaconess Hospital Corp. | Method and composition for testing patients with metabolic depleting diseases |
| US5130147A (en) * | 1991-05-01 | 1992-07-14 | Hannu Karu | Cholesterol lowering colloidal food product containing meat and omega fatty acid and process for preparing |
| JP3354582B2 (ja) | 1991-09-30 | 2002-12-09 | サントリー株式会社 | オメガ９系高度不飽和脂肪酸およびこれを含有する脂質の製造方法 |
| DE4133694C2 (de) * | 1991-10-11 | 1993-10-07 | Fresenius Ag | Verwendung einer Emulsion mit mehrfach ungesättigten Fettsären zur i.v.-Verabreichung zur Behandlung von Hauterkrankungen |
| US5260336A (en) * | 1992-04-30 | 1993-11-09 | New England Deaconess Hospital Corporation | Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness |
| JPH0633087A (ja) | 1992-07-17 | 1994-02-08 | Nippon Oil & Fats Co Ltd | 粉末油脂組成物 |
| JPH0741421A (ja) | 1993-05-28 | 1995-02-10 | Suntory Ltd | ロイコトリエンｂ４ （ｌｔｂ４ ）による医学的症状の予防及び改善剤 |
| JP3770628B2 (ja) * | 1994-08-09 | 2006-04-26 | サントリー株式会社 | 遅延型アレルギー反応を介する医学的症状の予防及び改善剤 |
| PT790056E (pt) * | 1995-08-07 | 2005-02-28 | Suntory Ltd | Preventivo ou remedio para doencas provocadas por anormalidades nos tecidos cartilaginosos |
| JP2941787B2 (ja) | 1997-08-14 | 1999-08-30 | 常盤薬品工業株式会社 | 多価不飽和脂肪酸を含有する医薬組成物および健康食品 |
| JP3804452B2 (ja) * | 1998-03-24 | 2006-08-02 | 日本新薬株式会社 | 肝炎治療剤 |
| US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
| JP4391673B2 (ja) * | 2000-08-08 | 2009-12-24 | 花王株式会社 | 油脂組成物 |
| DE10065123B4 (de) | 2000-12-28 | 2012-12-20 | Robert Bosch Gmbh | Verfahren zur Steuerung einer Diagnose eines Katalysators im Abgas eines Verbrennungsmotors |
| EP1411129B1 (en) * | 2001-07-02 | 2010-02-10 | Suntory Holdings Limited | Process for producing fat comprising triglyceride containing highly unsaturated fatty acid |
-
2004
- 2004-01-20 JP JP2004012207A patent/JP4721642B2/ja not_active Expired - Fee Related
-
2005
- 2005-01-19 EP EP05704085A patent/EP1707198B1/en not_active Not-in-force
- 2005-01-19 DK DK05704085.9T patent/DK1707198T3/da active
- 2005-01-19 WO PCT/JP2005/000941 patent/WO2005067914A1/ja not_active Application Discontinuation
- 2005-01-19 CN CN2005800008604A patent/CN1842329B/zh active Active
- 2005-01-19 AU AU2005205662A patent/AU2005205662B2/en not_active Ceased
- 2005-01-19 CA CA2540272A patent/CA2540272C/en not_active Expired - Fee Related
- 2005-01-19 US US10/562,716 patent/US8436047B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1707198B1 (en) | 2012-12-19 |
| CN1842329B (zh) | 2011-09-14 |
| WO2005067914A1 (ja) | 2005-07-28 |
| EP1707198A4 (en) | 2007-03-21 |
| US20060217442A1 (en) | 2006-09-28 |
| JP4721642B2 (ja) | 2011-07-13 |
| CA2540272C (en) | 2014-05-27 |
| CA2540272A1 (en) | 2005-07-28 |
| JP2005206476A (ja) | 2005-08-04 |
| AU2005205662A1 (en) | 2005-07-28 |
| AU2005205662B2 (en) | 2011-05-19 |
| EP1707198A1 (en) | 2006-10-04 |
| US8436047B2 (en) | 2013-05-07 |
| CN1842329A (zh) | 2006-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2047863T3 (da) | Middel til forebyggelse eller behandling af inflammatoriske sygdomme | |
| DK1830843T3 (da) | Indolidon-derivater til behandling eller forebyggelse af fibrotiske sygdomme | |
| DK1771201T3 (da) | Sammensætninger og fremgangsmåder til behandling eller forebyggelse af oxalat-relateret sygdom | |
| DK1708992T3 (da) | Sulfonamidderivater til behandling af sygdomme | |
| DK1869025T6 (da) | Piperazin-substituerede benzothiophener til behandling af mentale lidelser | |
| ATE541841T1 (de) | Inhibitoren der replikation des human immunodeficiency virus | |
| DK1984357T3 (da) | 2,4-pyrimidindiaminforbindelser til behandling eller forebyggelse af autoimmunsygdomme | |
| DE602006016150D1 (de) | Vorbeugung von krankheiten bei kaiserschnitt-babies | |
| DK1917246T3 (da) | Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme | |
| ATE550329T1 (de) | Heterobicyclische sulfonamidderivate zur behandlung von diabetes | |
| DK1708991T3 (da) | Sulfonamid derivater til behandling af sygdomme | |
| ES2352576T8 (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana. | |
| DK3456707T3 (da) | 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme | |
| DK1685834T3 (da) | Anvendelse af pinolensyre til behandling af obesitet | |
| DK1871181T3 (da) | Kosttilskud til HIV-patienter | |
| BRPI0907624A2 (pt) | tratamento e prevenção de doenças cardíacas usando duas ou mais isoformas do fator de crescimento de hepatócito | |
| DK2056842T3 (da) | Modificeret galactosylceramid til behandling af cancerøse sygdomme | |
| DK2026819T3 (da) | Forebyggelse og/eller behandling af Alzheimers sygdom | |
| BRPI0815551A2 (pt) | Tratamento através de hucbc de doença beta-amiloide | |
| DK1734959T3 (da) | Forbindelser til behandling af skizofreni og/eller glukoregulerende abnormaliteter | |
| DK1750713T3 (da) | Anvendelse af imatinib til behandling af leversygdomme og vi-rusinfektioner | |
| DK1835907T3 (da) | Lægemidler til behandling eller forebyggelse af fibrotiske sygdomme | |
| DK2388317T3 (da) | Gen, som koder for en human glucokinasemutant, og anvendelser deraf til behandling eller forebyggelse af sygdom | |
| DK2148667T3 (da) | Anvendelse af cyclohexanhexolderivater til behandling af øjensygdomme | |
| DK1919290T3 (da) | Fremgangsmåder og produkter til behandling af sygdomme |